8-KLeadership ChangesRegulation FDExhibits & Filings

AGILENT TECHNOLOGIES, INC. 8-K Report, Executive Changes (Sep 19, 2013)

Filed September 19, 2013For Securities:A

Summary

Agilent Technologies, Inc. announced a significant strategic move on September 19, 2013: the Board of Directors has approved a plan to separate the company into two independent, publicly traded entities. This separation is planned to occur via a pro-rata spin-off of the electronic measurement business, which is structured to be tax-free for shareholders. The remaining business, focusing on life sciences, diagnostics, and applied markets, will continue under the Agilent Technologies, Inc. name. This move aims to unlock value by creating more focused companies, each with distinct strategic priorities and growth opportunities.

Key Highlights

  • 1Agilent Technologies is splitting into two independent publicly traded companies.
  • 2The separation will be executed through a pro-rata spin-off of the electronic measurement business.
  • 3The spin-off is intended to be tax-free for Agilent shareholders.
  • 4The life sciences, diagnostics, and applied markets business will remain as Agilent Technologies, Inc.
  • 5William P. Sullivan has been appointed President, while continuing as CEO and Board member.
  • 6Ronald S. Nersesian is appointed Executive Vice President and CEO-designate of the new electronic measurement company.
  • 7Nicolas H. Roelofs is no longer Senior Vice President and President of the Life Sciences Group.

Frequently Asked Questions

The company's Board of Directors has approved a plan to separate Agilent into two independent companies to unlock value and allow each entity to focus on its distinct strategic priorities and growth opportunities within their respective markets.

The separation is planned to be effected through a pro-rata spin-off of the electronic measurement business. This method is intended to be tax-free for Agilent's shareholders.

The remaining business, which consists of the life sciences, diagnostics, and applied markets segments, will retain the Agilent Technologies, Inc. name.

William P. Sullivan has been appointed President, continuing as CEO and Board member. Ronald S. Nersesian has been appointed Executive Vice President and CEO-designate of the new electronic measurement company. Nicolas H. Roelofs is no longer serving as Senior Vice President and President of the Life Sciences Group.